for most of allison parker’s adult life, the goals that most people take for granted were complicated by her own body.
parker has suffered from crohn’s disease, an autoimmune, chronic inflammatory disease of the digestive tract, since she was 12 years old. at that time, she says, “no one would listen” to her parents’ concern about the severity of her condition.“finally, my dad just carried me into the clinic and waited for us to get a referral.” after that, says parker, she was diagnosed with crohn’s, which was initially kept under control with oral medication. “i was fairly stable through my teens and early twenties,” says parker, by this time a registered nurse. “then i had a major flare-up and the crohn’s got very much worse.” so, parker and her physician worked together to determine the most effective long-term treatment for her condition.
“for any patient with crohn’s disease or ulcerative colitis, the treating physician, in conjunction with the patient, makes a very careful decision as to which therapy may be best suited for the individual,” says dr. cynthia seow of the university of calgary’s division of gastroenterology and hepatology in the department of medicine.
once the treatment has been determined, “the primary goal is to optimize that treatment,” she adds. “there should be only two reasons for stopping a therapy,” emphasizes dr. seow. “they are, if there is no response despite optimization of the initial agent or if the patient has a significant adverse effect [to the medication].”